Features Pricing Learn Reverse Splits Tracker Shelf & ATM Tracker Warrant Tracker PIPE Deal Tracker Weekly Report FAQ API Sign In →
73 /100
HIGH RISK
Score updated Aug 28, 2026

DRIO — DarioHealth Corp. Dilution Risk Tracker

Track DRIO dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track DRIO — Get alerts when the score changes →

As of August 28, 2026, DarioHealth Corp. (DRIO) has a DilutionWatch DilutionScore of 73/100, rated HIGH dilution risk. DarioHealth Corp. has a market capitalization of $56.67M, 9.80M shares outstanding, 21 institutional holders tracked. Stored dilution-related fields include 23.5K outstanding warrants.

This page includes automatically generated factual summaries from DilutionWatch data. It is not financial advice, not investment research, and not a recommendation. Do your own research. Read the full disclaimer and terms of service.

Score Breakdown

📋 Offering Ability
72
💰 Cash Runway
85
📊 Float Risk
42
⚠️ Warrant Exposure
15
🔄 Convertible Debt
40

Dilution Forecast

Watch
Minor dilution signals detected
model est. 20%
💰 Capital Raise model 35%
• Low cash runway: 6 months remaining
📉 Score Deterioration model 10%
• Score in HIGH risk zone (73/100)
🔔 Track DRIO — Get forecast alerts →

Market Data

Market Cap$56.67M
Shares Outstanding9.80M
Float5.26M
Cash$13.96M
Debt$39.65M
Short InterestN/A

Institutional Holdings

QoQ: ↑ 23.6% shares (2026Q1 vs prior)
21 institutional holders · 908.6K shares
#1 Nantahala Capital Management, LLC 610.7K shares
#2 VANGUARD CAPITAL MANAGEMENT LLC 131.8K shares
#3 GEODE CAPITAL MANAGEMENT, LLC 61.9K shares
+ 17 more holders Sign up free to view →

Institutional holder totals are aggregated from ownership filings and may use a different share basis or reporting date than public float. They are not a reconciliation against tradeable float.

Short Interest

Short Interest85.8K
Days to Cover3.7
% of Float1.6%
FINRA data as of Jul 31, 2026

Recent SEC Activity

xbrl XBRL CONVERTIBLE 2025-12-31
xbrl XBRL WARRANT 2025-12-31
Full SEC filing analysis available with free account

Recent News

No recent news

Factual DRIO Dilution Snapshot

DarioHealth Corp. (DRIO) has a DilutionScore of 73/100, rated High dilution risk. Score date: August 28, 2026.

This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.

Track DRIO Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking DRIO — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required

Related Stocks — HIGH Risk

Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles:

Browse all 8,024+ tracked stocks →

📖 Dilution Education
→ Complete Dilution Guide for Retail Investors → Anti-Dilution Provisions Explained → Stock Dilution Red Flags to Watch → Understanding Shelf Registrations
More Research for DRIO
DRIO FDA Catalyst Timeline & Biotech Grade — BiotechSigns

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.